CNOT7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.733210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.902010E-01
Normal-vs-Stage2
6.403900E-02
Normal-vs-Stage3
2.961900E-02
Normal-vs-Stage4
1.872190E-01
Stage1-vs-Stage2
5.257000E-01
Stage1-vs-Stage3
1.408170E-01
Stage1-vs-Stage4
9.590800E-01
Stage2-vs-Stage3
3.516400E-01
Stage2-vs-Stage4
5.690600E-01
Stage3-vs-Stage4
9.117500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.928990E-01
Normal-vs-AfricanAmerican
3.606800E-01
Normal-vs-Asian
1.014270E-02
Caucasian-vs-AfricanAmerican
5.594400E-01
Caucasian-vs-Asian
1.021400E-01
AfricanAmerican-vs-Asian
4.859900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.289000E-01
Normal-vs-Female
9.532300E-02
Male-vs-Female
6.088200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.209700E-02
Normal-vs-Age(41-60Yrs)
2.981200E-01
Normal-vs-Age(61-80Yrs)
1.718790E-01
Normal-vs-Age(81-100Yrs)
7.758400E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.989000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.332600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.972000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.234580E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.337860E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.748770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.961500E-03
Normal-vs-Daily Drinker
7.915300E-03
Normal-vs-Weekly Drinker
8.475600E-02
Normal-vs-Occasional Drinker
6.771800E-01
Normal-vs-Social Drinker
5.029400E-01
Non Drinker-vs-Daily Drinker
9.108600E-01
Non Drinker-vs-Weekly Drinker
4.010200E-01
Non Drinker-vs-Occasional Drinker
1.991890E-02
Non Drinker-vs-Social Drinker
8.704900E-03
Daily Drinker-vs-Weekly Drinker
5.113000E-01
Daily Drinker-vs-Occasional Drinker
2.554300E-02
Daily Drinker-vs-Social Drinker
6.298700E-03
Weekly Drinker-vs-Occasional Drinker
1.236410E-01
Weekly Drinker-vs-Social Drinker
9.130500E-02
Occasional Drinker-vs-Social Drinker
8.847800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.689000E-01
Normal-vs-Grade 2
3.528000E-02
Normal-vs-Grade 3
4.296100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.804000E-01
Grade 1-vs-Grade 3
6.691200E-01
Grade 1-vs-Grade 4
2.689000E-01
Grade 2-vs-Grade 3
3.008600E-01
Grade 2-vs-Grade 4
3.528000E-02
Grade 3-vs-Grade 4
4.296100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.202200E-01
Normal-vs-NonDiabetic
1.389410E-01
Diabetic-vs-NonDiabetic
8.470400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.294500E-02
Normal-vs-NoPancreatitis
1.943770E-01
Pancreatitis-vs-NoPancreatitis
2.804400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.028600E-01
Normal-vs-N1
4.181700E-02
N0-vs-N1
2.543800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.021400E-01
Normal-vs-TP53-NonMutant
5.241400E-01
TP53-Mutant-vs-TP53-NonMutant
3.696800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
